Table 1.

IC₅₀ of diosmetin and 5-FU as monotherapy or combination therapy in HCT116 and HT29 cells.

Treatment	Drug	HCT116 Cells IC50 (μg/mL)	HT29 Cells IC50 (μg/mL)
Monotherapy	Diosmetin	4.16 ± 1.3	22.06 ± 2.7
	5-FU	0.83 ± 0.0	1.65 ± 0.8
Combination therapy	Diosmetin	1.38 ± 0.8	6.03 ± 0.3
	5-FU	0.27 ± 1.1	1.20 ± 0.0